US2010226960A1PendingUtilityA1

Natural biodegradable matrices and uses thereof

Assignee: SURMODICS INCPriority: Sep 21, 2005Filed: Sep 21, 2006Published: Sep 9, 2010
Est. expirySep 21, 2025(expired)· nominal 20-yr term from priority
A61L 2300/232A61K 9/0024A61L 31/16C08B 33/02C08B 31/04C08B 33/04A61L 2300/252A61K 9/2027A61L 2300/258A61L 27/58A61L 29/085C08L 3/02A61L 27/34B05D 7/52C09D 103/18A61K 9/205A61K 9/0051A61L 31/042C09D 103/02B05D 1/36A61L 27/54A61L 2300/604A61L 27/20C08B 31/006A61L 2300/606C08L 3/12A61K 47/34A61L 31/10A61L 2420/02A61L 29/16A61P 43/00
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Matrices formed from a natural biodegradable material and that exhibit surface degradation in the presence of an enzyme are described. Matrices including a bioactive agent can be implanted or formed in a subject for release of the bioactive agent upon degradation of the matrix. The matrix can be provided in various forms, including coatings for implantable devices, implants, and in-situ formed matrices. The matrix can also be in the form of a medical device having a structure that is used to treat a medical condition.

Claims

exact text as granted — not AI-modified
1 . A method of delivering a bioactive agent to a subject comprising the steps of:
 providing a matrix of natural biodegradable material comprising bioactive agent entrapped within the matrix, wherein the matrix has a surface, and wherein the matrix is implanted or immobilized within the subject; and   allowing the surface to be contacted with an enzyme, wherein the matrix prevents the enzyme from entering the matrix, wherein the enzyme degrades the matrix at the surface, and wherein bioactive agent is released from the matrix upon degradation of the natural biodegradable material.   
   
   
       2 . The method of  claim 1 , wherein the matrix is in the form of a coating on an implantable medical article. 
   
   
       3 . The method of  claim 1 , wherein the matrix is in the form of an in situ-formed hydrogel. 
   
   
       4 . The method of  claim 1 , wherein the matrix is in the form of an implantable device. 
   
   
       5 . The method of  claim 1 , wherein the natural biodegradable material comprises a natural biodegradable polymer. 
   
   
       6 . The method of  claim 5 , wherein the natural biodegradable material comprises a natural biodegradable polysaccharide. 
   
   
       7 . The method of  claim 6 , wherein the natural biodegradable polysaccharide is selected from the group consisting of maltodextrin, polyalditol, and amylose. 
   
   
       8 . The method of  claim 1 , wherein the matrix is formed of cross-linked natural biodegradable polymers. 
   
   
       9 . The method of  claim 1 , wherein the natural biodegradable material has a molecular weight of less than 100,000 Da. 
   
   
       10 . The method of  claim 1 , wherein the natural biodegradable material has a molecular weight of less than 50,000 Da. 
   
   
       11 . The method of  claim 1 , wherein the natural biodegradable material has a molecular weight in the range of 1000 Da to 10,000 Da. 
   
   
       12 . The method of  claim 1 , wherein the step of allowing, the enzyme is a carbohydrase. 
   
   
       13 . The method of  claim 12 , wherein the step of allowing, the enzyme is α-amylase. 
   
   
       14 . The method of  claim 1  wherein the bioactive agent is selected from the group consisting of polypeptides, polynucleotide, polysaccharides, viral particles, and cells. 
   
   
       15 - 20 . (canceled) 
   
   
       21 . The method of  claim 1 , wherein the natural biodegradable material has a molecular weight of less than 500,000 Da. 
   
   
       22 . The method of  claim 1 , wherein the natural biodegradable material has a molecular weight of less than 250,000 Da. 
   
   
       23 . The method of  claim 1 , wherein the matrix is formed from a composition comprising natural biodegradable polymers comprising pendent polymerizable groups. 
   
   
       24 . The method of  claim 23 , wherein the pendent polymerizable groups are selected from the group consisting of vinyl groups, acrylate groups, methacrylate groups, ethacrylate groups, 2-phenyl acrylate groups, acrylamide groups, methacrylamide groups, itaconate groups, and styrene groups. 
   
   
       25 . The method of  claim 1 , wherein the matrix is formed from a composition comprising natural biodegradable polymers at a concentration in the range of 5-50% (w/v). 
   
   
       26 . The method of  claim 25 , wherein the matrix is formed from a composition comprising natural biodegradable polymers at a concentration in the range of 20-50% (w/v).

Join the waitlist — get patent alerts

Track US2010226960A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.